TransScan expands chairman Kirshner’s duties

Breast imaging device developer TransScan of Ramsey, NJ, has expanded chairman Hal Kirshner’s duties to include those of president and CEO. Kirshner joined TransScan in May 1999. Before that he had served as president and CEO of Trex Medical and president of Trex subsidiary Lorad (SCAN 5/12/99).

Under Kirshner’s chairmanship, TransScan received premarket approval clearance from the Food and Drug Administration for improvements in the design and operation of its TS-2000 electrical impedance breast scanning system (SCAN 11/24/99). The FDA initially cleared the unit last April for use as an adjunct to mammography for follow-up exams in patients with equivocal mammograms.